Author:
Hayes-Jordan Andrea A.,Lewis Valerae O.
Publisher
Springer Berlin Heidelberg
Reference48 articles.
1. Bacci G, Picci P, et al. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing’s sarcoma of bone: results of two sequential studies. J Chemother. 1993;5(4):247–57.
2. Black JO, Coffin C, Anderson J Hawkins D, McCarville ME, Kao SC, Randall RL, Hayes-Jordan A, Parham D, Spunt S. Nonrhabdomyosarcoma myosarcoma soft tissue sarcomas in children, adolescents, and young adults: overview of COG ARST0332, A report from the Children’s Oncology Group. 2013 CTOS Annual Meeting, New York. 2013.
3. Briccoli A, Rocca M, et al. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol. 2010;19(4):193–9.
4. Burdach S, Jurgens H, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing’s sarcoma. J Clin Oncol. 1993;11(8):1482–8.
5. Clark J, Rocques PJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7(4):502–8.